Showing results (171-180 of 588) with videos related to

Sort By:
Pageof 59
Clinical Genitourinary Cancer|October 25, 2007
Potential histologic and molecular predictors of response to temsirolimus in patients with advanced renal cell carcinomaDaniel Cho, Sabina Signoretti, Sandra Dabora, et al.
AJR. American Journal of Roentgenology|June 20, 2008
Perfusion MDCT enables early detection of therapeutic response to antiangiogenic therapyAdeel Sabir, Rachel Schor-Bardach, Carol J Wilcox, et al.
Molecular Cancer Therapeutics|August 12, 2010
Renal cancer resistance to antiangiogenic therapy is delayed by restoration of angiostatic signalingRupal S Bhatt, Xiaoen Wang, Liang Zhang, et al.
Gene|March 29, 2026
Mapping prostate cancer pathobiology: A review of genetically engineered mouse models (GEMMs)Filippo Pederzoli, Hubert Pakula, Silvia Rodrigues, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 12, 2011
Investigative pathology: leading the post-genomic revolutionDavid M Berman, Marcus W Bosenberg, Robin L Orwant, et al.
Plos One|September 4, 2009
Systems-level modeling of cancer-fibroblast interactionRaymond C Wadlow, Ben S Wittner, S Aidan Finley, et al.
Small Gtpases|October 12, 2020
Exploring a role for fatty acid synthase in prostate cancer cell migrationMario De Piano, Valeria Manuelli, Giorgia Zadra, et al.
Cancer Research|March 30, 2011
Differential expression of S6K2 dictates tissue-specific requirement for S6K1 in mediating aberrant mTORC1 signaling and tumorigenesisCaterina Nardella, Andrea Lunardi, Giuseppe Fedele, et al.
The American Journal of Pathology|February 20, 2010
Establishment and genomic characterization of mouse xenografts of human primary prostate tumorsCarmen Priolo, Michelle Agostini, Natalie Vena, et al.
Journal of Translational Medicine|December 23, 2011
High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinomaXiaoen Wang, Liang Zhang, S Nahum Goldberg, et al.
Pageof 59